BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/16/2021 7:46:10 AM | Browse: 972 | Download: 2052
Publication Name World Journal of Diabetes
Manuscript ID 67981
Country China
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Basic Study
Article Title Inhibitory effect of maspinon neovascularization in diabetic retinopathy
Manuscript Source Unsolicited Manuscript
All Author List Feng Qiu and Hui-Juan Tong
ORCID
Author(s) ORCID Number
Feng Qiu http://orcid.org/0000-0001-7634-721X
Hui-Juan Tong http://orcid.org/0000-0002-9733-5602
Funding Agency and Grant Number
Funding Agency Grant Number
Liaoning Province Natural Science Foundation 2020-BS-277
Corresponding Author Hui-Juan Tong, PhD, Assistant Professor, Department of Nursing, Shenyang Medical College, No. 146 North Huanghe Avenue, Shenyang 110034, Liaoning Province, China. thj_9921@163.com
Key Words Maspin; Diabetic retinopathy; Neovascularization; Vascular endothelial growth factor; Hypoxia-inducible factor 1-alpha
Core Tip The aim of our study was to evaluate the effectiveness of intravitreal injection of recombinant human maspin on neovascularization in diabetic retinopathy. A mouse model of oxygen-induced retinopathy was used to simulate neovascularization in diabetic retinopathy. Maspin inhibited neovascularization in this model by modulating the hypoxia-inducible factor 1-alpha/vascular endothelial growth factor pathway, which provides a potential and effective strategy for the treatment of diabetic retinopathy.
Publish Date 2021-12-16 07:46
Citation Qiu F, Tong HJ. Inhibitory effect of maspin on neovascularization in diabetic retinopathy. World J Diabetes 2021; 12(12): 2050-2057
URL https://www.wjgnet.com/1948-9358/full/v12/i12/2050.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i12.2050
Full Article (PDF) WJD-12-2050.pdf
Full Article (Word) WJD-12-2050.docx